Ratna S Dewi1, Maksum Radji2, Rizka Andalusia3. 1. Faculty of Pharmacy, University of Indonesia, Depok, Indonesia. 2. Department of Pharmaceuticals, University of Indonesia, Depok, Indonesia. 3. Department of Pharmaceutical Installation, Dharmais Cancer Hospital, Jakarta, Indonesia.
Abstract
OBJECTIVES: This study aimed to evaluate the appropriateness of antibiotic use and factors associated with outcomes among sepsis patients in an intensive care unit (ICU). METHODS: This cross-sectional study was carried out from February to May 2017 and included all adult patients with sepsis or septic shock admitted to the ICU of Dharmais Cancer Hospital, Jakarta, Indonesia. Data were collected from the patients' medical records. RESULTS: A total of 60 patients with sepsis or septic shock were admitted to the ICU during the study period. The most common source of infection was hospital-acquired pneumonia (61.7%) and the majority had two or more comorbidities (93.3%). There were 115 antibiotic regimens prescribed. Overall, 33.3% of patients were prescribed inappropriate types of antibiotics and 51.7% were given an inappropriate dosage. The mortality rate was 68.3%. There was a statistically significant association between patient outcome and inappropriate doses of antibiotics (P = 0.034), although not inappropriate types of antibiotics (P = 0.050). A multivariate analysis indicated that the main factors influencing patient outcome were septic shock and the presence of at least two comorbidities (P <0.050 each). CONCLUSION: Inappropriate doses of antibiotics, a diagnosis of septic shock and the presence of at least two comorbidities were found to significantly increase the mortality rate of sepsis patients admitted to an ICU in Indonesia.
OBJECTIVES: This study aimed to evaluate the appropriateness of antibiotic use and factors associated with outcomes among sepsis patients in an intensive care unit (ICU). METHODS: This cross-sectional study was carried out from February to May 2017 and included all adult patients with sepsis or septic shock admitted to the ICU of Dharmais Cancer Hospital, Jakarta, Indonesia. Data were collected from the patients' medical records. RESULTS: A total of 60 patients with sepsis or septic shock were admitted to the ICU during the study period. The most common source of infection was hospital-acquired pneumonia (61.7%) and the majority had two or more comorbidities (93.3%). There were 115 antibiotic regimens prescribed. Overall, 33.3% of patients were prescribed inappropriate types of antibiotics and 51.7% were given an inappropriate dosage. The mortality rate was 68.3%. There was a statistically significant association between patient outcome and inappropriate doses of antibiotics (P = 0.034), although not inappropriate types of antibiotics (P = 0.050). A multivariate analysis indicated that the main factors influencing patient outcome were septic shock and the presence of at least two comorbidities (P <0.050 each). CONCLUSION: Inappropriate doses of antibiotics, a diagnosis of septic shock and the presence of at least two comorbidities were found to significantly increase the mortality rate of sepsis patients admitted to an ICU in Indonesia.
Entities:
Keywords:
Antibiotics; Drug Prescription; Indonesia; Intensive Care Units; Sepsis; Septic Shock; trends
Authors: Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney Journal: Clin Infect Dis Date: 2007-03-01 Impact factor: 9.079
Authors: Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren Journal: Clin Infect Dis Date: 2009-07-01 Impact factor: 9.079
Authors: Anand Kumar; Paul Ellis; Yaseen Arabi; Dan Roberts; Bruce Light; Joseph E Parrillo; Peter Dodek; Gordon Wood; Aseem Kumar; David Simon; Cheryl Peters; Muhammad Ahsan; Dan Chateau Journal: Chest Date: 2009-08-20 Impact factor: 9.410
Authors: Ricard Ferrer; Antonio Artigas; Mitchell M Levy; Jesús Blanco; Gumersindo González-Díaz; José Garnacho-Montero; Jordi Ibáñez; Eduardo Palencia; Manuel Quintana; María Victoria de la Torre-Prados Journal: JAMA Date: 2008-05-21 Impact factor: 56.272
Authors: David F Gaieski; Mark E Mikkelsen; Roger A Band; Jesse M Pines; Richard Massone; Frances F Furia; Frances S Shofer; Munish Goyal Journal: Crit Care Med Date: 2010-04 Impact factor: 7.598
Authors: Son Ngoc Do; Chinh Quoc Luong; My Ha Nguyen; Dung Thi Pham; Nga Thi Nguyen; Dai Quang Huynh; Quoc Trong Ai Hoang; Co Xuan Dao; Thang Dinh Vu; Ha Nhat Bui; Hung Tan Nguyen; Hai Bui Hoang; Thuy Thi Phuong Le; Lien Thi Bao Nguyen; Phuoc Thien Duong; Tuan Dang Nguyen; Vuong Hung Le; Giang Thi Tra Pham; Tam Van Bui; Giang Thi Huong Bui; Jason Phua; Andrew Li; Thao Thi Ngoc Pham; Chi Van Nguyen; Anh Dat Nguyen Journal: PLoS One Date: 2022-10-14 Impact factor: 3.752
Authors: Lama Nazer; Maria A Lopez-Olivo; John A Cuenca; Wedad Awad; Anne Rain Brown; Aseel Abusara; Michael Sirimaturos; Rachel S Hicklen; Joseph L Nates Journal: Support Care Cancer Date: 2022-10-10 Impact factor: 3.359